hrp0097p2-222 | Growth and Syndromes | ESPE2023

Height control using estradiol valerate considering chronological and bone age in patient with Marfan Syndrome

Kim Insung , Hwang JiHoon , Sung Juyoung , Eun Kim Sung , Lee Dong-Yun , Kim Min-Sun , Yoon Cho Sung , Jin Dong-Kyu , Seok Choi Doo

Introduction: Estrogen treatment can be used for pediatric patients with Marfan syndrome who wish to control the rate of excessive height growth. However, the appropriate timing of treatment initiation is controversial and studies were limited. In this study, the authors aimed to find out when the initiation of estradiol therapy is most appropriate for controlling height growth rate in patients with Marfan syndrome.Methods:</stro...

hrp0098p1-10 | Bone, Growth Plate and Mineral Metabolism 1 | ESPE2024

Causality between Sex Hormones and Bone Mineral Density in Childhood: Age- and Tanner stage-matched Sex Hormone Level May be an Early Interpreter of Pediatric Bone Fragility

Eun Kim Sung , Ki Kim Seul , Hee Kim Shin , Kyoung Cho Won , Soon Cho Kyoung , Ho Jung Min , Bae Ahn Moon

This study aimed to investigate the impact of hypogonadism on bone mineral density (BMD) in children and adolescents with chronic diseases to determine the relationship between sex hormones and BMD. Information of children and adolescents with chronic diseases, such as haemato-oncologic, rheumatoid, gastrointestinal, and endocrinologic diseases, was retrospectively collected. Relationship between sex- and Tanner stage-matched z-scores for sex hormones and sex- and age-matched ...